Group 1 - The core viewpoint of the news is that Aohua Endoscopy has seen a stock price increase of 5.3%, reaching 50.86 CNY per share, with a total market capitalization of 6.849 billion CNY [1] - Aohua Endoscopy, established on October 27, 1994, specializes in the research, production, and sales of electronic endoscope equipment and related medical consumables, with 92.35% of its revenue coming from endoscope equipment [1] - The company is located in Minhang District, Shanghai, and was listed on November 15, 2021 [1] Group 2 - Among the top ten circulating shareholders of Aohua Endoscopy, one fund from GF Fund Management, the GF Healthcare Stock A (004851), has entered the list, holding 1.7267 million shares, which is 1.28% of the circulating shares [2] - The GF Healthcare Stock A fund was established on August 10, 2017, and has a current scale of 5.247 billion CNY, with a year-to-date return of 19.8% [2] - The fund's performance ranks 2665 out of 4218 in its category this year, and it has achieved a cumulative return of 93.64% since inception [2] Group 3 - The fund manager of GF Healthcare Stock A is Wu Xingwu, who has been in the position for 10 years and 258 days, managing assets totaling 9.853 billion CNY [3] - During his tenure, the best fund return achieved was 105.25%, while the worst return was -37.23% [3]
澳华内镜股价涨5.3%，广发基金旗下1只基金位居十大流通股东，持有172.67万股浮盈赚取442.03万元